How Big is the Humanized Liver Mice Model Market?

The humanized liver mice model market is steadily growing, with its value projected to reach US$178 million by 2033, up from US$104 million in 2024. This market expansion is driven by a compound annual growth rate (CAGR) of 5.6% during the forecast period. Humanized liver mice models have become indispensable in biomedical research, particularly for studying liver diseases and testing new drugs. These models offer a more accurate representation of human liver physiology, making them invaluable for preclinical testing and drug development. The growing prevalence of liver diseases, such as hepatitis and liver cancer, further underscores the importance of these models in medical research. Additionally, advancements in genetic engineering have led to the development of more sophisticated and reliable models, enhancing their utility in research. While the market faces challenges, such as high costs and regulatory hurdles, the increasing demand for personalized medicine and the ongoing innovation in genetic technologies are expected to drive continued growth in the humanized liver mice model market, making it a key segment in the broader biomedical research field.